课题基金 / 基金详情

Phase I/II Trial Tetrathiomolybdate (TM) in Pts w/ Usual Interstitial Pneumonia

Phase I/II Trial Tetrathiomolybdate (TM) in Pts w/ Usual Interstitial Pneumonia
I/II 期试验四硫代钼酸盐 (TM) 在患有普通间质性肺炎的患者中的应用
批准号：
7039821
负责人：
KEVIN R FLAHERTY
金额：
$2.44万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
项目状态：
已结题
起止时间：
2004-03-01 至 2005-02-28
来源：
https://reporter.nih.gov/project-details/7039821
关键词：
clinical researchclinical trial phase Iclinical trial phase IIhuman subjecthuman therapy evaluationmolybdenumpatient oriented researchpulmonary fibrosis /granulomarespiratory disorder chemotherapy

项目成果

KEVIN R FLAHERTY的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
Forging a road to personalized medicine in interstitial lung diseases
海外基金